1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSarcoma Fund Grant is sponsored by Memorial Sloan Kettering Cancer Center (Sarcoma Center). Provides funding for innovative sarcoma-related research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Sarcoma Center Funded Research Projects | Memorial Sloan Kettering Cancer Center For appointments, call: 800-525-2225 Sarcoma Center Funded Research Projects A core focus of the Sarcoma Center at Memorial Sloan Kettering is to provide funding for innovative sarcoma-related research through the Sarcoma Fund grant that was established in 2019.
Molecular Biology Program Project: Exploiting R-loops as an Epigenetic Vulnerability in Ewing Sarcoma Department of Radiation Oncology Project: Investigating the Role of MDM2 Amplification in Liposarcoma Project: Targeting eIF4A in Liposarcoma Project: Developing a Machine-Learning Model to Predict Responses to Immune Checkpoint Blockade in Sarcomas.
Molecular Biology Program Project: Role of Senescence in the Resistance Landscape to CDK4/6i in DDLS. Human Oncology and Pathogenesis Program Project: Targeting DNA Repair Defects in FET Fusion Sarcomas. Memorial Hospital Research Laboratories Project: Activating Neutrophils by Immunogenic Recombinant Modified Vaccinia Viruses for the Treatment of “Immune-Desert” Sarcomas.
Memorial Hospital Research Laboratories Project: Establish Appropriate Cellular Contexts and Vulnerabilities to Model Sarcoma-Relevant Translocations across Cell Lineages: Exploiting the Gene Fusion Promiscuity as a Common Pathway of Transformation.
Human Oncology and Pathogenesis Program Project: Understanding and Targeting MYC-Mediated Tumorigenesis and Plasticity in Angiosarcoma Cancer Biology and Genetics Program Project: Cancer Stem Cells in NF1-Associated MPNST Memorial Hospital Research Laboratories Project: CD24xCD3 Bispecific Antibody (BsAb) for Compartmental Immunotherapy and Radioimmunotherapy in Desmoplastic Small Round Cell Tumors Molecular Pharmacology Program Project: Combination Epigenetic Therapies for BAF-Deficient Sarcomas Project: The Efficacy of CDK4 Inhibition and Immune Checkpoint Blockade in Locally Advanced, Resectable, and Metastatic Dedifferentiated Liposarcoma — Identifying Senescence and Immune Biomarkers Predictive of Clinical Benefit Human Oncology and Pathogenesis Program Project: Immune Evasion and Immunotherapeutic Intervention of PRC2-Deficient Tumors Memorial Hospital Research Laboratories Project: Investigating HIF1A Signaling to Identify Predictive Markers and Therapeutic Targets in Desmoid Tumors Project: Targeting Lung Macrophages in Metastatic Osteosarcoma Cancer Biology and Genetics Program Project: Determinants of Escape from Natural Killer Cells in Sarcoma Multipart Sarcoma-Related Projects Project: Optimizing T Cell-Based Immunotherapies for Pediatric Sarcomas and AML Two sarcoma research projects are being funded as part of this larger project: Human Oncology and Pathogenesis Program Project: TCR Immunotherapy Targeting Shared Neoantigens Derived from Sarcoma-Associated EWSR1-WT1 Oncogenic Gene Fusions Human Oncology and Pathogenesis Program Project: Axl/EphA2 Dual Targeted CAR T Cells Modified to Secrete the IL-18 Cytokine for the Treatment of Osteosarcoma Career Development Awards These awards are given to early-career researchers.
Human Oncology and Pathogenesis Program Project: Therapeutic Targeting of a Recurrent Fusion-Derived “Public” Neoantigen Expressed by Desmoplastic Small Round Cell Tumors Using T Cell Receptor (TCR) Gene Therapy (renewal) Project: Assessing the Efficacy of Radiation Therapy Combined with CDK4/6 Inhibition in the Treatment of Retroperitoneal Dedifferentiated Liposarcoma Memorial Hospital Research Laboratories Project: Modeling and Investigating the Pathogenesis of MYOD1 and RAS Mutant Spindle and Embryonal Rhabdomyosarcoma: Two Histotypes with Opposite Clinical Behavior Human Oncology and Pathogenesis Program Project: Therapeutic Targeting of a Recurrent Fusion-Derived “Public” Neoantigen Expressed by Desmoplastic Small Round Cell Tumors Using T Cell Receptor (TCR) Gene Therapy Project: Multi-Armored CAR T Cells for Sarcoma Project: A Phase II Study of the Dual Adenosine Receptor Antagonist AB928 with the Anti-PD-1 Antibody Zimberelimab in Patients with Advanced Dedifferentiated Liposarcoma and Undifferentiated Pleomorphic Sarcoma Cancer Biology and Genetics Program Project: Dissecting Tumor Heterogeneity in Undifferentiated Pleomorphic Sarcomas Project: Identifying Chromatin-Pathway Dependencies in FUS-DDIT3 Expressing Myxoid Liposarcoma Using Chemical and Genetic Strategies Project: Development of a Customized, Multi-Modal Treatment Response Assessment Measurement in Gastrointestinal Stromal Tumors Project: CDK4 Inhibition to Trigger Anti-Tumor Immunity and Augment Efficacy of Combined Checkpoint Blockade in Patients with Metastatic Liposarcomas Sarcoma Center Information for Patients and Families
According to the current listing, eligibility includes: Awarded internally to researchers at Memorial Sloan Kettering Cancer Center for sarcoma-related research. Confirm the full requirements in the official notice before applying.
Sarcoma Fund Grant is funded by Memorial Sloan Kettering Cancer Center (Sarcoma Center). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article